In the latest trading session, 0.83 million Conduit Pharmaceuticals Inc (NASDAQ:CDT) shares changed hands as the company’s beta touched 2.25. With the company’s most recent per share price at $1.24 changing hands around $0.03 or 2.48% at last look, the market valuation stands at $5.84M. CDT’s current price is a discount, trading about -31512.9% off its 52-week high of $392.00. The share price had its 52-week low at $1.09, which suggests the last value was 12.1% up since then.

Conduit Pharmaceuticals Inc (NASDAQ:CDT) trade information

Instantly CDT is in green as seen in intraday trades today. With action -5.34%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -81.92%, with the 5-day performance at -5.34% in the red. However, in the 30-day time frame, Conduit Pharmaceuticals Inc (NASDAQ:CDT) is -72.57% down.

Conduit Pharmaceuticals Inc (NASDAQ:CDT)’s Major holders

Among Mutual Funds, the top two as of Oct 31, 2024 were Fidelity Small Cap Index Fund and Vanguard Extended Market Index Fund. With 2.33 shares estimated at $2870.0 under it, the former controlled 0.06% of total outstanding shares. On the other hand, Vanguard Extended Market Index Fund held about 0.06% of the shares, roughly 2.03 shares worth around $2495.0.